# Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

> **NCT02139215** · — · COMPLETED · sponsor: **PeriPharm** · enrollment: 72 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02139215
- **Lead sponsor:** PeriPharm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139215, "Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02139215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*